Targeting bone metastases in prostate cancer: improving clinical outcome. [electronic resource]
- Nature reviews. Urology Jun 2015
- 340-56 p. digital
Publication Type: Journal Article; Review
1759-4820
10.1038/nrurol.2015.90 doi
Antineoplastic Agents--therapeutic use Biomarkers, Tumor Bone Density Conservation Agents--therapeutic use Bone Neoplasms--drug therapy Denosumab--therapeutic use Diphosphonates--therapeutic use Drug Therapy, Combination Humans Imidazoles--therapeutic use Male Osteoblasts--physiology Osteolysis Pain--physiopathology Prognosis Prostatic Neoplasms, Castration-Resistant--mortality Quality of Life Radioisotopes--therapeutic use Radiopharmaceuticals--therapeutic use Radium--therapeutic use Treatment Outcome Zoledronic Acid